ArticleBritish journal of cancer2022

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.

Mattia Cremona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.